Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.
52 Week high
52 Week low
The Motley Fool • 1 hours ago • ABTAbbott Stock: Bear vs. Bull
Fox Business • 1 day ago • ABTAbbott India warns of potential laxative syrup shortages amid production halt
Reuters • 1 day ago • ABTAbbott India warns of laxatives shortage in tussle with Goa regulator
PRNewsWire • 1 day ago • ABTAbbott Completes Acquisition of Bigfoot Biomedical
PRNewsWire • 2 days ago • ABTAbbott Declares 399th Consecutive Quarterly Dividend
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.